Pain relief technique for patients undergoing breast reduction surgery
Bilateral Rhomboid Intercostal Block Versus Erector Spinae Plane Block for Perioperative Analgesia in Patients Undergoing Bilateral Reduction Mammoplasty
This study is testing two different pain relief techniques to see if they can help people aged 18-65 recover more comfortably after breast reduction surgery while using fewer opioids.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 72 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | Female |
| Sponsor | Zagazig University Government |
| Locations | 2 sites (Zagazig, Alsharqia and 1 other locations) |
| Trial ID | NCT06225895 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of bilateral rhomboid intercostal blocks and erector spinae plane blocks for managing postoperative pain in patients undergoing bilateral reduction mammoplasty. The study aims to minimize the reliance on opioids, which can have significant side effects, by utilizing regional anesthesia techniques that are easier and safer. Participants will receive general anesthesia along with the nerve blocks to assess their impact on pain management and recovery. The trial focuses on patients aged 18-65 with specific health criteria undergoing elective surgery.
Who should consider this trial
Good fit: Ideal candidates are women aged 18-65 with a BMI of 35 or less, undergoing elective bilateral reduction mammoplasty.
Not a fit: Patients with certain medical conditions, such as heart disease or those on specific medications, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve postoperative pain management and recovery for patients undergoing breast reduction surgery.
How similar studies have performed: Other studies have shown promising results with similar regional anesthesia techniques, suggesting potential for success in this trial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient acceptance. * Age 18-65 years old. * BMI ≤ 35 kg/m2 * ASA I - II. * Elective bilateral reduction mammoplasty surgery under general anesthesia. * Duration of surgery within five hours Exclusion Criteria: * Patients on anti-platelet, anticoagulant, or B blocker drugs. * Patients with acute decompensated heart failure, hypertension, heart block, coronary disease, Asthma * History of allergy to the local anesthetics (LA) agents used in this study, * Skin lesion at the needle insertion site, * Those with bleeding disorders, sepsis, liver disease, psychiatric disorders, and pregnancy.
Where this trial is running
Zagazig, Alsharqia and 1 other locations
- Faculty of medicine, zagazig university — Zagazig, Alsharqia, Egypt (Recruiting)
- Shereen E Abd Ellatif — Zagazig, Alsharqia, Egypt (Recruiting)
Study contacts
- Principal investigator: Shereen E Abd Ellatif, M.D. — Faculty of medicine, zagazig university
- Study coordinator: Shereen E Abd Ellatif, M.D.
- Email: shosh.again@gmail.com
- Phone: +20552336654
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.